Novel neurosensory testing in cancer patients treated with the epothilone B analog, ixabepilone

Background: We have previously established the recommended phase II dose (RPTD) of ixabepilone as 40 mg/m(2) administered over 1 h repeated every 3 weeks with neuropathy as a cumulative dose-limiting toxicity. We expanded the cohort at the RPTD to include detailed assessment of nerve damage in these...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Goel, S., Goldberg, G. L., Kuo, D. Y.-S., Muggia, F., Arezzo, J., Mani, S.
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2008
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2733111/
https://ncbi.nlm.nih.gov/pubmed/18644829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdn420
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker